Tomio Kimura

459 total citations
22 papers, 376 citations indexed

About

Tomio Kimura is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Tomio Kimura has authored 22 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Infectious Diseases. Recurrent topics in Tomio Kimura's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and NF-κB Signaling Pathways (3 papers). Tomio Kimura is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and NF-κB Signaling Pathways (3 papers). Tomio Kimura collaborates with scholars based in Japan, Germany and Spain. Tomio Kimura's co-authors include Kiyoshi Oizumi, Shigeru Ushiyama, Hiroshi Nishino, Masaaki Miyamoto, Toshio Sada, Hiroyuki Koike, Yoshihiro Wada, Saburo Fukui, Atsuo Tanaka and Tetsuo Omata and has published in prestigious journals such as International Journal of Cancer, Applied Microbiology and Biotechnology and European Journal of Pharmacology.

In The Last Decade

Tomio Kimura

22 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomio Kimura Japan 12 164 112 52 46 41 22 376
Paresh K. Patel India 11 145 0.9× 252 2.3× 25 0.5× 26 0.6× 49 1.2× 25 553
Jorge Gomez‐Galeno United States 12 332 2.0× 251 2.2× 36 0.7× 39 0.8× 22 0.5× 17 626
Darrin Dabideen United States 9 122 0.7× 159 1.4× 30 0.6× 34 0.7× 22 0.5× 16 573
Allen W. Harrison United States 11 133 0.8× 162 1.4× 34 0.7× 44 1.0× 15 0.4× 15 319
R.N. Seelye New Zealand 15 277 1.7× 129 1.2× 22 0.4× 60 1.3× 150 3.7× 40 645
Harold E. Osborne United States 9 217 1.3× 69 0.6× 71 1.4× 85 1.8× 13 0.3× 11 455
F Arcamone Italy 13 264 1.6× 98 0.9× 64 1.2× 136 3.0× 62 1.5× 35 456
Matthias OTTO Germany 6 145 0.9× 95 0.8× 23 0.4× 40 0.9× 4 0.1× 8 386
Jü Zhu China 15 250 1.5× 170 1.5× 43 0.8× 100 2.2× 7 0.2× 34 435
Heinz‐Werner Kleemann Germany 9 164 1.0× 70 0.6× 16 0.3× 70 1.5× 52 1.3× 16 370

Countries citing papers authored by Tomio Kimura

Since Specialization
Citations

This map shows the geographic impact of Tomio Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomio Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomio Kimura more than expected).

Fields of papers citing papers by Tomio Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomio Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomio Kimura. The network helps show where Tomio Kimura may publish in the future.

Co-authorship network of co-authors of Tomio Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Tomio Kimura. A scholar is included among the top collaborators of Tomio Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomio Kimura. Tomio Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ushiyama, Shigeru, Tomoko Yamada, Yukiko Murakami, et al.. (2007). Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects. European Journal of Pharmacology. 578(1). 76–86. 34 indexed citations
3.
Wada, Yoshihiro, Kohei Shimada, Kotaro Sugimoto, Tomio Kimura, & Shigeru Ushiyama. (2005). Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes. International Immunopharmacology. 6(2). 144–155. 15 indexed citations
4.
Wada, Yoshihiro, Kohei Shimada, Tomio Kimura, & Shigeru Ushiyama. (2005). Novel p38 MAP kinase inhibitor R-130823 suppresses IL-6, IL-8 and MMP-13 production in spheroid culture of human synovial sarcoma cell line SW 982. Immunology Letters. 101(1). 50–59. 13 indexed citations
5.
Wada, Yoshihiro, Kazuyo Yamada, Takaichi Shimozato, et al.. (2004). R-130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models. European Journal of Pharmacology. 506(3). 285–295. 34 indexed citations
6.
Kazui, Miho, Nobuhiro Kobayashi, Tomoaki Komai, et al.. (2002). Anti-HIV-1 Activities and Pharmacokinetics of New Arylpiperazinyl Fluoroquinolones. Bioorganic & Medicinal Chemistry Letters. 12(5). 739–742. 33 indexed citations
7.
Kazui, Miho, Naotoshi Yamamura, Haruo Iwabuchi, et al.. (2001). Mechanism for Production of Pharmacologically Active Metabolite of CS-747, A New Anti-Platelet Agent. Drug Metabolism and Pharmacokinetics. 16(supplement). 78–79. 4 indexed citations
8.
9.
Hagihara, Masahiko, Tomio Kimura, Tomoaki Komai, et al.. (1999). Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: A new class of anti-HIV agents. Bioorganic & Medicinal Chemistry Letters. 9(21). 3063–3068. 41 indexed citations
10.
Komai, Tomoaki, Tomio Kimura, Takashi Nishigaki, et al.. (1999). A New Fluoroquinolone Derivative Exhibits Inhibitory Activity against Human Immunodeficiency Virus Type 1 Replication. Chemotherapy. 45(1). 48–55. 17 indexed citations
11.
12.
13.
Oizumi, Kiyoshi, Hiroshi Nishino, Hiroyuki Koike, et al.. (1989). Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.. The Japanese Journal of Pharmacology. 51(1). 57–64. 57 indexed citations
14.
Oizumi, Kiyoshi, Hiroshi Nishino, Hiroyuki Koike, et al.. (1989). Antihypertensive Effects of CS-905, a Novel Dihydropyridine Ca++ Channel Blocker. The Japanese Journal of Pharmacology. 51(1). 57–64. 16 indexed citations
15.
Esaki, Nobuyoshi, et al.. (1984). , a suicide substrate of l-methionine γ-lyase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 785(1-2). 54–60. 4 indexed citations
16.
Kimura, Tomio, Nobuyoshi Esaki, Hidehiko Tanaka, & Kenji Soda. (1984). Inactivation of amino acid racemase by S-(N-methylthiocarbamoyl)-D,L-cysteine.. Agricultural and Biological Chemistry. 48(2). 383–388. 3 indexed citations
17.
Kimura, Tomio, et al.. (1983). Crystallization and Characterization of a Novel Aminopeptidase fromTrichosporon cutaneum. Agricultural and Biological Chemistry. 47(11). 2483–2493. 3 indexed citations
18.
Kurihara, Norio, Yuzuru Sanemitsu, Tomio Kimura, Masaharu Kobayashi, & Minoru Nakajima. (1970). Studies on BHC Isomers and their Related Compounds:Part I. Stepwise Synthesis of 3, 4, 5, 6-Tetrachlorocyclohexene-1 (BTC) Isomers. Agricultural and Biological Chemistry. 34(5). 784–789. 1 indexed citations
19.
Kurihara, Norio, Yuzuru Sanemitsu, Tomio Kimura, Masaharu Kobayashi, & Minoru Nakajima. (1970). Studies on BHC Isomers and their Related Compounds. Agricultural and Biological Chemistry. 34(5). 784–789. 8 indexed citations
20.
Kimura, Tomio, et al.. (1961). 2106) Research on High Tensile Bolt Friction Joint (2) : Relating to Roughness of Plate Surface and Coefficient of Friction(Structure). Transactions of the Architectural Institute of Japan. 69.1(0). 657–660. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paresh K. Patel Breakdown of academic impact, for papers by Jorge Gomez‐Galeno Breakdown of academic impact, for papers by Darrin Dabideen Breakdown of academic impact, for papers by Allen W. Harrison Breakdown of academic impact, for papers by R.N. Seelye Breakdown of academic impact, for papers by Harold E. Osborne Breakdown of academic impact, for papers by F Arcamone Breakdown of academic impact, for papers by Matthias OTTO Breakdown of academic impact, for papers by Jü Zhu Breakdown of academic impact, for papers by Heinz‐Werner Kleemann
Rankless by CCL
2026